Taro Pharmaceutical Industries Ltd $144.71

down -1.09


24/7/2014 04:02 PM  |  : TARO  
Industries :
Get Trend Analysis Icon Get TARO Trend Analysis - it has outperformed the S&P 500 by 119%

Partner Headlines

  1. Israel's Market Appears Unfazed By Rising Conflict

    IBD
  2. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  3. Novo, Other Medicals Display Healthy Action

    IBD
  4. Pharmaceutical Industry on the Cusp Of Change

    GuruFocus
  5. Mylan Bid Gets Rejected, But Generic-Drugmaker Rises

    IBD
  6. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  7. Caesarstone, Check Point Show Strong Fundamentals

    IBD
  8. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  9. Ascending Bases Are Rare, But Can Spark Big Gains

    IBD
  10. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  11. Generic-Drug Makers Actavis, Mylan To Report Q4 Soon

    IBD
  12. Actavis, Perrigo Pace Strong Generic Drugs Group

    IBD
  13. Top Funds Like Facebook And Health Care Stocks

    IBD
  14. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  15. US Stock Futures Up Ahead Of Pending Home Sales

    Benzinga
  16. Taro Commences Tender Offer to Buybackup Up to $200M of Ordinary Shares ...

    Benzinga
  17. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  18. UPDATE: Credit Suisse Initiates Coverage on Taro Pharmaceutical on Market ...

    Benzinga
  19. Drug Firm Actavis Eyes Growth From A Buyout, Lidoderm

    IBD
  20. Actavis, Warner Chilcott Take Another Step Forward

    IBD
  21. Taro to Defer Annual General Meeting to September 12, 2013

    Benzinga
  22. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  23. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  24. Generic Drugs: Watson Up, Impax Awaits FDA Decision

    IBD
  25. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  26. BlueMountain Capital Says Shareholders of Taro Should Reject Sun Offer

    Benzinga
  27. Taro Special Committee Rejects Proposal from Sun Pharma

    Benzinga
  28. Taro Pharmaceutical Shareholder, Guardian Point Capital, Issues Letter ...

    Benzinga
  29. Mellanox, Several Other Israeli Stocks Show Strength

    IBD
  30. Taro Special Committee Continues to Evaluate Sun Pharma's Proposal to Acquire ...

    Benzinga
  31. IsZo Capital Calls upon Special Committee of Taro Pharmaceutical to Reject ...

    Benzinga
  32. Israel's Best-Rated Stocks Show Growth Plenty Of Problems

    IBD
Trading Center